The final countdown is on for the Pulmonary Hypertension Association’s PHPN Symposium, “Influencing the Practice: The Art and Science of Treating Pulmonary Hypertension.” It takes place from Sept. 5-7 in Washington, D.C.
The Symposium is recognized as one of the premier networking and CME/CE-earning events for health care professionals who treat pulmonary hypertension (PH). It offers 30 educational sessions from the top experts in the field. Among the highly anticipated sessions at this year’s Symposium:
Aaron B. Waxman, M.D., Ph.D., presents on “Using Cardiopulmonary Exercise Testing in PH Evaluation and Management.” He reviews the basics of exercise physiology in exercise testing and several forms of exercise testing that can be used in PH diagnosis and assessment.
Tim Lahm, M.D., Jacqueline R. Szmuszkovicz, M.D., and Corey E. Ventetuolo, M.D., M.S., discuss “Future Directions and Emerging Therapies in PH” on novel treatment approaches for PH and promising new therapies for both adults and children with the condition.
Vallerie V. McLaughlin, M.D., offers an update from the 6th World Symposium on Pulmonary Hypertension (WSPH).